Related Experiment Videos
Critical threshold cerebral hypoperfusion causes Alzheimer's disease?
1Department of Neurosciences, UCSD School of Medicine, La Jolla, CA 92093, USA. jdelator@ucsd.edu
Acta Neuropathologica
|July 21, 1999
Summary
Alzheimer's disease (AD) pathology is hypothetically explained by impaired cerebral perfusion, exacerbated by aging and other conditions. This critical threshold hypoperfusion destabilizes brain cells, leading to neurodegeneration and cognitive decline.
Area of Science:
- Neuroscience
- Pathology
- Gerontology
Background:
- The exact cause of Alzheimer's disease (AD) remains elusive despite extensive research.
- Key pathological events in AD development require a unifying hypothetical explanation.
Purpose of the Study:
- To present a hypothetical model for Alzheimer's disease pathogenesis.
- To explain the interplay of aging and reduced cerebral perfusion in AD development.
- To discuss potential therapeutic targets based on the proposed pathogenesis.
Main Methods:
- Review of basic and clinical evidence.
- Hypothetical assembly of pathological events.
- Analysis of contributing factors to cerebral hypoperfusion.
Main Results:
- Impaired cerebral perfusion, originating in microvasculature, disrupts glucose and oxygen delivery.
- Breakdown of metabolic energy pathways in brain cells is linked to hypoperfusion.
- Critical threshold cerebral hypoperfusion, driven by aging and other conditions, initiates neurodegeneration.
Conclusions:
- Advanced aging combined with conditions lowering cerebral perfusion are necessary for AD onset.
- Critical threshold cerebral hypoperfusion is a self-perpetuating process leading to neuronal destabilization.
- This hypoperfusion model explains AD hallmarks like plaques, tangles, and amyloid angiopathy.